Murali M. Chintagumpala, MD

Location

  • Texas Medical Center

Specialty

Cancer

Phone: 832-822-4266
Fax: 832-825-1456

Contact Information

6621 Fannin
Suite 1510.15
Houston, TX 77030

Co-Director, Brain Tumor Program
Director, Solid Tumor Programs
Co-Director, Retinoblastoma Program

Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine

Education

School Education Degree Year
Baylor College of Medicine fellowship Hematology-Oncology 1992
Columbus Hospital Program residency Pediatrics 1988
University Teaching Hospital residency Jr. Resident Medical Officer 1984
Government General Hospital internship Rotating Internship 1983
Madras Medical College medical school Doctor of Medicine 1981

About Murali Chintagumpala

Dr. Murali Chintagumpala is a Co-Director of the Brain Tumor Program, Director of the Solid Tumor Programs, and Co-Director of the Retinoblastoma Program. He oversees all clinical and clinical research activities involving children with brain tumors and solid tumors at Texas Children's Cancer and Hematology Center. His specific interests include the management of children with all brain tumors, retinoblastoma, bone tumors, and kidney tumors. 

His extensive background in treating children with brain tumors has led him to become the Principal Investigator representing Baylor College of Medicine in the Pediatric Brain Tumor Consortium. He serves as member of the Brain Tumor Committee within the Children’s Oncology Group (COG) and serves an active role at Texas Children's Cancer Center where he is Co-Director of our Brain Tumor Program.

In addition, Dr. Murali is a Clinical Co-Director of the Retinoblastoma Center of Houston. At the national level, he serves as chair of the Retinoblastoma Committee within the Children’s Oncology Group and is a leader in conducting clinical trials involving children with retinoblastoma.

As Director of our Solid Tumor Programs, he is an experienced clinician expert in the management of children with bone tumors, liver tumors and kidney tumors. He is the principal investigator of a multi-institutional study designed to improve survival in patients with osteosarcoma as part of the Bone Tumor Program.

Dr. Murali is a graduate of Madras Medical College in India. He then completed his residency at Columbus Hospital in Chicago, Illinois, then attended Baylor College of Medicine where he graduated from the Fellowship Program in Pediatric Hematology/Oncology. He is board certified in pediatric Hematology/Oncology by the American Board of Pediatrics.

Organization

Organization Name Role
American Society of Clinical Oncology (ASCO) Member
American Society of Pediatric Hematology and Oncology (ASPHO) Member
Children's Oncology Group (COG) Member
Children's Oncology Group (COG), Brain Tumor Committee Chair
Children's Oncology Group (COG), Renal Tumors Committee Chair
Children's Oncology Group (COG), Retinoblastoma Committee Chair
Pediatric Brain Tumor Consortium (PBTC) Member

Selected Publications

Related Videos

  • Embedded thumbnail for Q&A: Brain Tumor Program | Texas Children's Cancer Center
    Q&A: Brain Tumor Program | Texas Children's Cancer Center
  • Embedded thumbnail for Q&A: Brain Tumor Program
    Q&A: Brain Tumor Program